Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients ; volume:15 ; number:1 ; day:14 ; month:9 ; year:2020 ; pages:1-9 ; date:12.2020
Orphanet journal of rare diseases ; 15, Heft 1 (14.9.2020), 1-9, 12.2020
- Urheber
-
van den Dorpel, J. J. A.
Poelman, E.
Harlaar, L.
van Kooten, H. A.
van der Giessen, L. J.
van Doorn, P. A.
van der Ploeg, A. T.
van den Hout, J. M. P.
van der Beek, N. A. M. E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-020-01482-w
- URN
-
urn:nbn:de:101:1-2020110219400226885664
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- van den Dorpel, J. J. A.
- Poelman, E.
- Harlaar, L.
- van Kooten, H. A.
- van der Giessen, L. J.
- van Doorn, P. A.
- van der Ploeg, A. T.
- van den Hout, J. M. P.
- van der Beek, N. A. M. E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cognitive outcome of classic infantile Pompe patients receiving enzyme therapy
Effects of immunomodulation in classic infantile Pompe patients with high antibody titers
Antibody formation to enzyme therapy in classic infantile Pompe disease: implications of patient age
Chest MRI to diagnose early diaphragmatic weakness in Pompe disease
Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease
Late-onset Pompe disease: what is the prevalence of limb-girdle muscular weakness presentation?
A higher dose of enzyme therapy in patients with classic infantile Pompe disease seems to improve ventilator-free survival and motor function
Enzymersatztherapie bei Patienten mit infantiler Verlaufsform des Morbus Pompe in Deutschland
A Severe Form of Non-Classic Pompe's Disease with Normal Creatinine Kinase Level
Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
Infantile Pompe disease with intrauterine onset: a case report and literature review
Cognitive outcome of classic infantile Pompe patients receiving enzyme therapy
Effects of immunomodulation in classic infantile Pompe patients with high antibody titers
Antibody formation to enzyme therapy in classic infantile Pompe disease: implications of patient age
Chest MRI to diagnose early diaphragmatic weakness in Pompe disease
Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease
Late-onset Pompe disease: what is the prevalence of limb-girdle muscular weakness presentation?
A higher dose of enzyme therapy in patients with classic infantile Pompe disease seems to improve ventilator-free survival and motor function
Enzymersatztherapie bei Patienten mit infantiler Verlaufsform des Morbus Pompe in Deutschland
A Severe Form of Non-Classic Pompe's Disease with Normal Creatinine Kinase Level
Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
Infantile Pompe disease with intrauterine onset: a case report and literature review
Cognitive outcome of classic infantile Pompe patients receiving enzyme therapy
Effects of immunomodulation in classic infantile Pompe patients with high antibody titers
Antibody formation to enzyme therapy in classic infantile Pompe disease: implications of patient age
Chest MRI to diagnose early diaphragmatic weakness in Pompe disease
Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease
Late-onset Pompe disease: what is the prevalence of limb-girdle muscular weakness presentation?
A higher dose of enzyme therapy in patients with classic infantile Pompe disease seems to improve ventilator-free survival and motor function
Enzymersatztherapie bei Patienten mit infantiler Verlaufsform des Morbus Pompe in Deutschland
A Severe Form of Non-Classic Pompe's Disease with Normal Creatinine Kinase Level
Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy